JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Wnt/β-catenin

A3011 CHIR-99021 (CT99021)
31 Citation

Target: GSK-3

Summary: GSK-3 inhibitor

≥23.27 mg/mL
A8217 ICG 001
9 Citation

Summary: Wnt/β-catenin pathway inhibitor

≥27.43 mg/mL
A8685 Wnt-C59
4 Citation

Target: PORCN

Summary: PORCN inhibitor,highly potent and selective

.95 mg/mL

insoluble in H2O; ≥18
B2305 IWP-L6

Summary: Porcupine inhibitor,highy potent

≥22.45 mg/mL
A3512 IWP-2
9 Citation

Summary: Wnt production inhibitor,PORCN inhibitor

≥23.35 mg/mL
A4529 JW 55

Summary: PARP domain inhibitor

insoluble in H2O; ≥19.25 mg/mL
A8213 KY 02111

Summary: WNT signaling inhibitor

insoluble in H2O; ≥18.85 mg/mL
A8396 CHIR-99021 (CT99021) HCl
3 Citation

Target: GSK-3

Summary: GSK-3α/β inhibitor

≥25.1 mg/mL
A8600 Tankyrase Inhibitors (TNKS) 22

Summary: Tankyrase inhibitor
A8601 Tankyrase Inhibitors (TNKS) 49

Target: Tankyrases

Summary: Tankyrase inhibitor

≥22.45 mg/mL